With its handheld medical device, Head Diagnostics is using the eye to access the unique signals of the brain.

BrainsWay announced today that the FDA granted a label expansion for its deep transcranial magnetic stimulation (Deep TMS) ...

With its new investment, Beacon plans to scale its technology and operations. It aims to accelerate neurobiomarker discovery ...

XCath today announced the successful first-in-human use of its EVR robotic system to treat three patients with complex brain ...

Vicarious Surgical (NYSE:RBOT) today announced third-quarter financial results that included another delay in its surgical ...

LivaNova (Nasdaq: LIVN) today announced its new strategic roadmap and long-range financial plan at its 2025 Investor Day.

Siemens announced today that it intends to deconsolidate its remaining stake in Siemens Healthineers through a direct ...

(Nasdaq: OM)  shares took a big hit today on third-quarter results that failed to reach the consensus sales forecast.

A Boston Scientific (NYSE: BSX) official announced the enrollment of the first patients in the OPTIMIZE randomized controlled clinical trial.

Magstim announced today that the FDA cleared its magnetic stimulation technology for the treatment of chronic pain.

Minze Health announced that it entered into a three-year agreement with Medtronic to commercialize its overactive bladder ...

Augmedics announced today that it received FDA 510(k) clearance for X2, its next-generation augmented reality (AR) headset.